Pregnancy-specific glycoprotein (PSG) constitutes a major component of serum of pregnant women and appears to be essential for a successful pregnancy. Its function is, however, still unknown. Because of the evolutionary divergence between human and rodent PSG, functional studies may require a primate animal model. We have characterized PSG transcripts in a baboon placenta cDNA library and analyzed baboon genomic DNA. The main PSG isoform had the domain structure N-A1-B2-C similar to the human type IIa isoform. The type I isoform (N-A1-A2-B2-C) was also expressed. Fifteen similar PSG genes were identified of which at least nine were simultaneously expressed in third trimester baboon placenta. Thus, the baboon PSG family was as complex as that of humans. Recombinant baboon PSG (isoform IIa) had a molecular weight of 38 kDa and reacted with antibodies against human PSG. Comparative analysis of 43 N-domain amino acid sequences of PSG from four species and nine primate carcinoembryonic antigen subgroup N domain sequences identified a number of residues in the GFCCC ␤-sheet and FG loop that are probable candidates for PSG binding to its putative ligand.
INTRODUCTION
Primates and rodents synthesize a group of placental glycoproteins termed pregnancy-specific glycoprotein (PSG), (also known as Schwangerschafts Proteine 1 [SP1]) [1] [2] [3] [4] . In humans, PSG is produced by the syncytiotrophoblast starting as early as about the time of implantation [5] . Pregnancy-specific glycoprotein is released into the maternal circulation and increases in concentration as pregnancy proceeds, reaching a concentration of 200-400 g/ml at term [6] . Similarly, baboon, rhesus, and cynomolgus monkeys have been shown to synthesize PSG or a PSG-like protein in the placenta and to release it into the circulation of the pregnant female in a gestation-course-dependent way [3, [7] [8] [9] . In rodents, PSG is produced by the secondary giant cellspongiotrophoblast, i.e., the tissue corresponding to the syncytiotrophoblast [2, 4] . Although high levels of PSG are only seen in the syncytiotrophoblast, PSG cannot be considered to be entirely pregnancy specific because PSG mRNA has been demonstrated in fetal liver, salivary gland, testis, and myeloid cells [10, 11] .
Pregnancy-specific glycoprotein seems to be necessary for normal pregnancy. Thus, injection of antibodies specific 1 This work was supported by grants from the Swedish Cancer Society (0706-B97-25XAC) and the Swedish Medical Research Council (K2000-71X-09945-09C). for human PSG into pregnant monkeys was shown to induce abortion [12] . Moreover, in humans, lower serum PSG levels have been correlated with fetal growth retardation, fetal stress, and fetal loss [13] . It has been suggested that PSG may function as an inhibitor of cell-matrix interactions because most human PSGs (8 of 11) contain the tripeptide motif, arginine-glycine-asparic acid (RGD), at an exposed position in the N-terminal domain [14] . However, in mouse and rat PSG there is no RGD motif in the N-terminal domain [15] . Pregnancy-specific glycoprotein has also been suggested to have an immunomodulatory function [16] [17] [18] and an embryotrophic activity [19] , and to enhance platelet and white blood cell counts after bone marrow transplantation [20] .
In humans, there are 11 similar PSG genes (Ͼ90% sequence identity at the nucleotide level), clustered within a 700-kilobase (kb) region on chromosome 19q13.2 [21, 22] . In mouse and rat 15 and 4 different PSG genes, respectively, have been identified [15, 23] . The PSG subgroup, the carcinoembryonic antigen (CEA) subgroup and the CEACAM-ps6-11 subgroup constitute the CEA family [24, 25] , which in turn belongs to the immunoglobulin superfamily (IgSF) [26] . Human PSGs are made up of one Ig variable-like domain (N), followed by one to three Ig constant type 2-like domains of two different types (A and B), and a short hydrophilic tail (C). Common domain arrangements are type I (L-N-A1-A2-B2-C), type IIa (L-N-A1-B2-C), and type IIb (L-N-A2-B2-C) [27] [28] [29] , where L represents the signal peptide that is cleaved off in the mature protein. Mature PSGs from human placenta have molecular weights of 72, 64, and 54 kDa [24] and contain approximately 30% carbohydrate [30] . The rodent PSGs are made up of multiple N-domains followed by a single A domain. The following arrangements have been seen: (L-N1-N2-N3-A), (L-N1-N3-A), and (L-N1-N2-N3-N4-N5-A) [15] .
As a step to obtain a relevant animal model for functional studies of human PSG, we have characterized PSG transcripts in a baboon placenta cDNA library and L/N exons of baboon PSG genes and expressed PSG cDNAs as proteins in vitro.
MATERIALS AND METHODS

Screening of cDNA Library
A baboon (Papio hamadryas) placenta cDNA library constructed in Lambda ZAP II vector was obtained commercially (Stratagene, La Jolla, CA). The library contained cDNA from placenta of a wild-caught baboon that was 7-8 yr old and in the last trimester of pregnancy (140-160 days). The library was amplified in the Escherichia coli XL-1 blue MFRЈ strain, and the plaques were transferred to nylon filters (Boehringer Mannheim, Mannheim, Germany). A human PSG1d cDNA fragment containing L-B2 exons was labeled with digoxigenin (Boehringer Mannheim) and was then used as a probe to screen the library. Prehybridization and hybridization were carried out in 5ϫ SSC (1ϫ SSC ϭ 0.15 M NaCl, 0.015 M sodium citrate, pH 7.0), 0.1% N-lauroylsarcosine, 0.02% SDS, and 1% blocking reagent (Boehringer Mannheim), at 60ЊC for 18 h. Final washes were performed in 0.5ϫ SSC containing 0.2% SDS at 60ЊC for 30 min. Positive plaques were picked, mixed, and subjected to secondary and tertiary screenings. After the third screeing in vivo, single-clone excision of the 12 pBluescript phagemids containing positive inserts was performed and the resulting pBluescript phagemids were used for subsequent sequencing analysis.
Polymerase Chain Reaction Amplification of Baboon PSG L/N Exons and PSG cDNA Pools A consensus primer pair (#1 and #2) for baboon PSG L/N exon was constructed on the basis of sequence information from isolated baboon PSG cDNA clones and human PSG L/N exons [21] , corresponding to positions 14-34 and 350-370 of the exon, respectively. The sequences of these primers were 5Ј-CTTCTGGAAYCYGCCCACCA-3Ј and 5Ј-GAKATAAGGTGWAAYGTMCA-3Ј, respectively. A primer pair (#3 and #4) derived from the human CEA subgroup molecules [31] was also used to amplify baboon PSG L/N sequences. These primers were 5Ј-CGCGA-ATTCTGGAACCYRCCMAMCASTGC-3Ј and 5Ј-GTGCTGCAGCNYNGAACTGKCYRGTTRCTTCTTC-3Ј, corresponding to the sequence 15-37 and 348-373 of L/N exons of CEA subgroup genes, respectively. A primer (#5) with the sequence 5Ј-CCCTCCYCAGCCCCTY-CCTGCAC-3Ј, derived from L exon (position 9-31) of human PSG and a primer (#6) with the sequence 5Ј-GCTGAGTTAYGARCAGAGCAA-3Ј, from position 195-215 of human PSG B2 exons, were also utilized. In the sequence formulas, ambiguous bases are marked Y for T or C; K for G or T; W for A or T; M for A or C; R for A or G; S for C or G; and N for A or C or T or G.
For amplification of PSG L/N exon sequences from the baboon genome, total genomic DNA (100 ng per 50 l reaction) isolated from a baboon lymphoblastoid cell line, 26CB1 (European Collection of Cell Culture, UK), and primer pairs #1 ϩ #2 and #3 ϩ #4 (0.2 mM of each primer), respectively, were used. To amplify L-L/N exons from the placenta library a phage suspension (5 l in 50 l reaction mixture) of the baboon placenta cDNA library (titer ϭ 1 ϫ 10 9 plaque-forming units [pfu]) was used as template in combination with primer pairs #5 ϩ #2 or #5 ϩ #4. Other components in the polymerase chain reaction (PCR) were 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 100 mM of each dNTP, 0.001% gelatin, and 2.5 units of Thermus aquaticus (Taq) DNA polymerase (MBI, Vilnius, Lithuania). The samples were subjected to 34 cycles of PCR amplification at 95ЊC for 1 min, 51ЊC for 1 min, and 72ЊC for 1 min, except in the first cycle (95ЊC for 2 min), and the last cycle (72ЊC for 5 min), using a programmable thermal cycler (MJ Research, Inc., Watertown, MA).
To determine the relative frequency of alternatively spliced PSGs, phage suspensions of human and baboon placenta cDNA libraries and individual PSG-positive clones from the first cDNA library screening, respectively, and primer pair #5 ϩ #6 were used for PCR amplification. Except for the extension step for each cycle that was 72ЊC for 2 min instead of 1 min, all other parameters were the same as those mentioned above. The amplified DNA fragments were analyzed by electrophoresis in 1% agarose gel and visualized by ethidium bromide staining.
Subcloning and Sequencing
The PCR products of baboon PSG L/N and L-L/N exons were inserted into the plasmid pBluescript II SK(ϩ) (Strategene). Five to 10 individual recombinant clones containing the inserts of correct size from each amplification were sequenced using the dideoxy-chain-termination method with thermosequence fluorescent-labeled primer cycle sequencing kit (7-deaza dGTP) (Amersham Pharmacia Biotech, Solna, Sweden) and Cyt-5 labeled T7 and pUC/M13 reverse primers. For sequencing of isolated cDNA clones, the specific internal primers and AutoRead sequencing kit (Amersham Pharmacia Biotech) were also utilized.
Sequence Alignment and Phylogenetic Analysis
The Genetic Computer Group (GCG) software package version 10 was used to compare nucleotide and amino acid sequences. Nucleotides corresponding to the primers were excluded. The nucleic acid and deduced amino acid sequences were aligned using the PileUp program of the GCG package for progressive and pairwise alignments. Based on the alignment, the sequences of human PSG L/N exons, baboon PSG L/N exons, rodent PSG L/N exons, and a few human CEA subgroup L/N exons were used to make a distance matrix. For this purpose the minimum evolutionary distance in the PAUPsearch program was utilized. The trees were constructed using the neighbor-joining algorithm. Human CEA subgroup N-domain sequences were used as outgroups to make a phylogenetic tree of primate PSG N-domains. When phylogenetic analysis included CEA-related sequences from different species, human and mouse CD2 and human P 0 IgV sequences were used as outgroups. To estimate the confidence level of the branching topology in the phylogenetic trees, bootstrap analysis was performed. The values give the frequency (%) by which a particular branching point was obtained (500 replications). A value of Ͼ95 is considered reliable.
Expression of Recombinant Baboon PSGs and Immunodetection
To express baboon PSG58 and PSG70 cDNAs, primers located in the PSG cDNA L/N and B2 exons were used. They were 5Ј-GGGAGATCTCAAGTCACGATTGAAGCC-3Ј and 5Ј-CTCGAATTCAATGATGATGATGATGAT-GATGTGTCATGGATT-3Ј, respectively. Restriction endonuclease sites (underlined) for BglII and EcoRI were introduced in the primers to facilitate subsequent cloning to the DES vector, pMT/BiP/V5-His (Invitrogen, Carlsbad, CA). This vector makes the recombinant protein secretory. Using this cloning strategy, the mature recombinant proteins contain two extra amino acid residues (arginine and serine) at the N-terminal and six histidine residues at the C-terminal. The expression constructs were confirmed by sequencing and introduced into Drosophila Schneider (S2) cells using the standard calcium phosphate precipitation method. The supernatants of transient transfectants were collected 4 days post-transfection. Ten microliters of the supernatant were mixed with 10 l of 2ϫ SDS-PAGE sample buffer and subjected to electrophoresis. The proteins were then transferred to a polyvinylidene fluoride (PVDF) nylon membrane and probed with polyclonal rabbit anti-human PSG antibodies (Dako, Glostrup, Denmark) followed by swine anti-rabbit Ig antibody-horseradish peroxidase conjugate. The ECL Western blotting analysis system (Amersham, Buckinghamshire, UK) was utilized for the final detection.
RESULTS
Isolation and Characterization of Baboon PSG cDNA Clones
A baboon placenta cDNA library was screened with a probe corresponding to the L/N to B2 region of human PSG1d cDNA. One hundred fifty positive clones were obtained. Twelve of these were partially sequenced and were found to represent five different sequences similar to human PSG (Fig. 1) . One (B12) was almost of full length, while the other four were truncated. Clone B12 coded for a PSG with the domain formula (L-N-A1-B2-C) (Fig. 1) . Three additional clones (B10, B105, B98) coded for PSGs with the same domain formula while the fifth clone (B102) most likely coded for a PSG with the formula (L-N-A1-A2-B2-C). Clone B98 and B102 were alternatively spliced forms of the same PSG gene. The predicted N-domain sequences of the baboon PSG clones were found to be two amino acids shorter than the N-domain of human PSGs. None of the four baboon PSG species contained an RGD motif. When baboon and human PSG sequences were compared at the nucleotide level, the highest degree of identity was 83%, 90%, 86%, 87%, and 83% for the L, L/N, A1, A2, and B2 exons, respectively. Two different types of short, hydrophilic C-terminal tails were identified (Fig. 1A) . The tail encoded by clones B10, B12, B102, and B98 was different from all known human C-terminal tail sequences [22, 29] , while the one encoded by clone B105 was similar (66%) to the tail of human PSG3-4C5 and PSG5-3C5 [32, 33] . Baboon PSGs contained several potential glycosylation sites in the N, A1, and A2 domains (Fig. 1 ). The mature proteins should therefore be glycosylated in analogy with human PSGs. Interestingly, the B2 domain lacked any glycosylation sites.
To determine which of the different splice variants of PSG were preferentially expressed in baboon placenta the cDNA library was amplified by PCR with primers flanking the L and B2 exons (Fig. 2) . For comparison, a human placental cDNA library was also analyzed. The dominating splice form in baboon placenta was the type II splice variant (L-L/N-A1/A2-B2-C) (Fig. 2) . However, type I, III, and IV forms were also detected. In human placenta, types I and IV splice variants were more strongly expressed. Two faint bands (ϳ1900 base pairs [bp] and ϳ300 bp) were nonspecifically amplified products as confirmed by sequencing (Fig. 2) . A predominance of type II transcripts was also found when phage suspensions of isolated PSGpositive clones were used as template in PCR; 40 out of 55 baboon PSG clones yielded a band corresponding to type II transcripts (data not shown).
Size of Baboon PSG Gene Family and PSG Genes Expressed in Placenta
To obtain an estimate of the number and identity of PSG genes in the baboon genome and of PSG genes expressed in baboon placenta, we took advantage of the fact that all human CEA-PSG genes contain a single L/N exon [21] and that PSG transcripts lacking the L/N exon are rare [28] . The baboon PSG L/N exon fragments from total genomic DNA and the L-L/N exon fragments from the placental cDNA library were amplified. From each source 50 and 40 clones were sequenced. The results are summarized in Table 1 and Figure 3 . All genes except one allele of PSG69 were in the correct reading frame. Altogether 15 different baboon PSG L/N exon sequences were identified, 14 in genomic DNA and 9 in the cDNA library (8 of which were also seen among the genomic sequences and 1, PSG70, only in the cDNA library). The PSG transcripts were present in different frequencies in the placental cDNA library; PSG58 was found in nine of 40 cDNA clones and, therefore, seems to be the main PSG species expressed in baboon term placenta ( Table 1 ). The baboon L/N exon sequences were very similar to each other (ϳ90% at the nucleotide level) and showed 83-91% identity to human PSG genes and less than 65% identity to rodent PSGs.
Expression of Recombinant Baboon PSGs
Baboon PSG58 (B10) and PSG70 (B12) cDNA clones were used for expression studies. The molecular weight of the two PSGs was calculated to 38 400 Da, assuming that two of two NXS/NXT sites (B10) and two of three NXS/ NXT sites (B12) in the PSGs are substituted by a complex type of carbohydrate chain of a molecular weight of 2800 Da [34] . Figure 4 shows an immunoblot of supernatants from Schneider cells transfected with baboon PSG58 and PSG70 constructs, respectively, using polyclonal rabbit anti-human PSG antibodies for detection. A prominent band with a molecular weight of 38 kDa was seen for both constructs. The value is in excellent agreement with the expected molecular weight. Figure 5A shows a dendrogram of the deduced peptide sequences of all human and baboon PSG L/N exons. Using any human CEA subfamily member as functional outgroup, all N-domains of baboon PSGs were clustered together in one group and all N-domains of human PSGs in another. The bootstrap value for the branching point between the two species was 100, thus the branching is highly reliable (Fig. 5A ). Some N-domain sequences within each species were clustered together. However, only for PSG56 and PSG57 and for PSG58 and PSG59, respectively, were the bootstrap values high enough to consider the branching points almost reliable. The degree of homology between human and baboon PSG N-domains was 73-89% at the protein level.
Phylogenetic Analysis of PSG N-Domains
If members of the CEA subgroup from primates and rodents were included in the phylogenetic analysis, and either human or mouse CD2 or human P 0 protein was used as an outgroup, the primate PSGs were clustered together with primate CEA subfamily molecules while rodent PSGs were excluded (Fig. 5B) . Again, baboon PSGs were most closely related to human PSGs, while N-domain sequences of baboon CEA subgroup members were subgrouped together with the corresponding human CEA subgroup sequences. Very similar phylogenetic trees were obtained using the nucleotide sequences (data not shown).
Multiple Alignment of Primate and Rodent PSG N-Domains
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with a hypothetical PSG ligand. Eight positions in the PSG N-domain may be glycosylated. The glycosylation sites were located in the A-strand (in a few baboon PSGs only), in the loop between the B-and C-strands (in primate PSGs and one mouse PSG), in the C-, CЈ-, CЈЈ-strands or loops between them (three positions in some rodent PSGs only), in the loops between the D-and E-strands and between the E-and F-strands (in practically all PSGs), and in the beginning of the G-strand (rodent PSGs only). This leaves residues in the C-, CЈ-, and F-strands as well as in the CCЈ, CЈCЈЈ, and FG loops free to interact with the hypothetical PSG ligand.
Arginine 64 and Asp82 were conserved in all species probably forming an intramolecular salt bridge [10] . Similarly, a number of amino acid residues essential for the characteristic Ig folding pattern were also conserved in all PSG N-domains from all four species. They were Val17, Leu19, Trp33, Gly63, Leu73, Ile75, Asp82, Gly84, and Tyr86 (Fig. 3) . The degree of sequence variability is shown as invariant residues (circles), similar residues (asterisks), and variant residues (unmarked) (Fig. 3) . The upper line in Figure 3 shows sequence variability for primates only and the lower line for all four species. Two regions, positions 37 to 60 and positions 88 to 108, corresponding to the CЈ-and CЈЈ-strands plus the CCЈ and CЈCЈЈ loops and the Gstrand plus the FG loop, respectively, displayed the most pronounced sequence variability. However, within these regions there were several relatively well-conserved residues.
A number of amino acid residues that are shared by human and baboon but are replaced by other residues in rodents were also identified. These were Ser12, Lys15, Glu16, Gln26, Tyr31, Thr46, Tyr61, Val67, Ala71, Leu74, Ser85, and Ile90. Tyrosine 44 in primate PSGs is deleted in rodent PSGs. These amino acid residues are distributed among most family members in a lineage-specific way and suggest a process of sequence homogenization during evolution.
Because the phylogenetic analysis using N and N1 (for rodents) domain amino acid sequences showed that rodent PSGs are less related to human PSGs than primate CEA subgroup members (Fig. 5B ) and that putative carbohydrate binding sites had a rather different distribution in rodent PSG N-domains compared to primate PSG N-domains (Fig.  3) , we focused further comparisons on CEA family members from primates. It is generally considered that the PSGs have a different physiological function than CEA or CEA-CAM1 [25, 36] . Therefore, direct sequence comparisons between PSG and CEA subfamily members in primates might indicate possible contact amino acids in a putative PSG binding site. Indeed, when consensus sequences of primate PSG N-domains were compared with N-domain sequences of expressed CEA subgroup molecules, several amino acid residues were readily identified that were conserved in primate PSGs (present in Ͼ90% of the sequences), while all or almost all primate CEA subgroup molecules contained an amino acid residue with different properties at the corresponding position (Fig. 6 ). They were Ile32, Gln37, Tyr 44, Thr46, Asp51, Ile55, Gly94, Asp95, Thr97, and Gly99. It is interesting to note that all these residues were located in the C-, CЈ-, and CЈЈ-strands or in the CCЈ, CЈCЈЈ, and FG loops.
DISCUSSION
Nonhuman primates have previously been shown to express PSG and PSG mRNA as revealed by immunological cross-reactivity with anti-human PSG antisera [3, [7] [8] [9] and by cross-hybridization with a human PSG cDNA probe [37] .
In this study we have characterized baboon PSGs and compared them with human PSGs. We found that 1) the degree of sequence homology was very high and that PSG from the two species had the same types of domain arrangements. However, in baboon the type II domain arrangement dominated while in humans the type I domain arrangement dominated. This finding suggests that the A domain is of less importance from a functional point of view. 2) Both the baboon and the human PSG gene families were large with Ն15 and 11 members, respectively. 3) Similar to human and rodent PSGs [28, 38, 39] , many baboon PSG genes and alternative splice forms of them were coordinately expressed in the placenta. 4) Recombinant baboon PSGs were shown to contain epitopes recognized by antibodies against human PSGs. 5) Finally, in contrast to all other CEA family molecules but in accordance with human and rodent PSGs, the C-terminal IgC-like domain did not contain any glycosylation sites [15] . The peptide back- bone of this PSG domain may either play a role in the formation of dimers (oligomers) or may in some way be involved in ligand interaction. We conclude that baboon PSG is sufficiently similar to human PSG for the baboon to constitute an adequate animal model for functional studies.
The size of recombinant baboon PSG from both cDNA clones was approximately 38 kDa, indicating that the two baboon PSGs were glycosylated to the same degree in Drosophila Schneider (S2) cells even though the B12 clone contained a third potential site for N-glycosylation. Perhaps the glycosylation sites at Asn77 and Asn81 in B12 are too close together for both to be glycosylated in the same molecule. In previous studies [7, 24, 37] , size heterogeneity of human and baboon PSGs from placenta was observed. Although the simultaneous expression of type I to IV splice forms contributes significantly to size heterogeneity, differential glycosylation of the PSG polypeptide may also contribute. In addition, dimerization of at least some PSGs may occur [30] .
The CEA gene family in humans is thought to have arisen by gene duplication from an ancestral CEACAM1-like gene. The genes in the PSG and CEA subgroups have evolved separately after an initial gene duplication event some 108 million yr ago or about the time of human-rodent divergence [15, 40, 41] . Phylogenetic analysis using N-domain sequences from human and baboon PSGs showed that PSG members within a species were more closely related to each other than to PSG members from the other species. The presence of lineage-specific residues and deletions, the lack of apparent counterparts between baboon and human PSG genes, and the difference in number of PSG genes in the two species support the view that the CEA-PSG gene family is still under the process of evolution by gene duplication and/or gene conversion, leading to sequence homogenization of each family member of a species. This conforms to the general pattern of evolution of multigene families. As can be seen from the comparative sequences alignment (Fig. 3) , however, the impact of the evolutionary processes is not random (see below).
The IgV-like N-domain has been shown to be the most important domain functionally in a number of IgSF molecules, including CD2, CD58, CD48, CD22, CD80, CTLA-4, and CEACAM1 (BGP), CEACAM5 (CEA), and CEA-CAM6 (NCA) [25, 36, 42] . In most cases the N-terminal domain alone contained the ligand binding site, even though this may not always be the case [25, 36, [42] [43] [44] [45] . There are good reasons to believe that the IgV-like N-terminal domain of the PSGs is the functionally most important. Although the crystal structure of the IgV-like N domain of a CEA family molecule has not yet been determined, molecular modeling based on x-ray crystallographic data from CD2, CD4, and Bence-Jones protein REI suggests that the domain is made up of two stacked pairs of antiparallel ␤-sheets, A, B, E, D and G, F, C, CЈ, CЈЈ, respectively, forming a ␤-barrel [29, 34, 35, 44, 45] . Interestingly, the epitopes of four monoclonal antibodies directed against the N-domain of CEA that were able to inhibit CEA-mediated cell adhesion were located in a GFCCЈ ␤-sheet [46] . Furthermore, all amino acid residues identified to be important for Neisseria meningitidis and Neisseria gonorrhoeae opacity-associated (Opa) protein binding were located on the GFCCЈ face of the human CEA subgroup molecules [35, 47] . The GFCCЈCЈЈ ␤-sheet in the CEA subfamily molecules is free of oligosaccharide side chains and most amino acid residues in the peptide chain are accessible to the solvent [34] .
A comparative alignment of the 43 PSG N-domain sequences from primates and rodents (Fig. 3) revealed that amino acid residues in the C-, CЈ-, and F-strands as well as the CCЈ, CЈCЈЈ, and FG loops are free to interact with the hypothetical ligand. If primate PSG N-domain sequences are considered separately, the carbohydrate-free area of the N-domain can be extended to the entire GFCCЈCЈЈ face. It should be noted, however, that these conclusions are based on the assumption that PSG is not forming dimers in solution, at least not via this face of the domain [48] . A number of amino acid residues on the GFCCЈCЈЈ face were well conserved particularly when primate and rodent sequences were considered separately. Furthermore, when primate PSG N-domain sequences were compared with primate CEA subgroup sequences (Fig. 6) , several residues were identified that were well conserved among the 26 primate PSG sequences, while in the CEA subgroup sequences (n ϭ 9) there were amino acid residues belonging to a different group of amino acids. Among 14 relatively wellconserved residues, 10 residues (Ile32, Gln37, Tyr 44, Thr46, Asp51, Ile55, Gly94, Asp95, Thr97, and Gly99) were the most conserved. Possibly, some or all of these are interacting with the putative ligand. Obviously, some amino acid residues that are conserved in the entire primate CEA family located on the GF CCЈCЈЈ face may also be involved in ligand binding such as Tyr34, Lys35, Gly36, Asp40, Ile45, Tyr48, and Lys92. That the corresponding amino acid residues at these positions in human CEA subfamily molecules are solvent exposed and able to interact with Opa proteins have been demonstrated in two recent studies [35, 47] .
Five of 15 baboon PSG N-domains and 8 of 11 human PSGs [14] contained the RGD motif at positions 93-95 in the N-domain, while mouse and rat PSGs lack this motif [15] . We have tested the hypothesis that human PSGs could act as inhibitors of integrin-matrix interactions. However, our experiments have not provided evidence that PSGs containing the RGD motif interact with integrins [Zhou and Hammarström, unpublished] . Moreover, a PSG11-derived peptide that contains the RGD sequence and was shown to bind to the promonocyte cell line THP-1 did not reveal a binding protein of the size of an integrin [17] . Thus, although G94 and D95 may be involved in the interaction with a PSG ligand it is probably not a classical RGD-dependent integrin-matrix interaction.
Finally, as commented upon by Holness and Simmons [43] , in spite of the very conserved patterns of domain folding and domain organization seen in members of the IgSF, there is a surprising diversity in their mode of interaction. Binding sites can be localized to single domains or involve faces encompassing several domains. Whichever is the case for primate PSGs remains to be elucidated. To understand the function of primate PSG is the primary objective for future studies.
